Roderick John Flower - Net Worth and Insider Trading
Roderick John Flower Net Worth
The estimated net worth of Roderick John Flower is at least $62,685 dollars as of 2024-09-21. Roderick John Flower is the Director of Antibe Therapeutics Inc and owns about 212,492 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $62,685. Details can be seen in Roderick John Flower's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roderick John Flower has not made any transactions after 2020-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Roderick John Flower
Roderick John Flower Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roderick John Flower owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of Roderick John Flower’s form 4 insider trades.
Insider Ownership Summary of Roderick John Flower
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-06-01 | Director |
Roderick John Flower Latest Holdings Summary
Roderick John Flower currently owns a total of 1 stock. Roderick John Flower owns 212,492 shares of Antibe Therapeutics Inc (TSX:ATE) as of June 1, 2020, with a value of $62,685.
Latest Holdings of Roderick John Flower
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-06-01 | 212,492 | 0.30 | 62,685 |
Holding Weightings of Roderick John Flower
Roderick John Flower Form 4 Trading Tracker
According to the SEC Form 4 filings, Roderick John Flower has made a total of 2 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Antibe Therapeutics Inc is the sale of 150,000 shares on June 1, 2020, which brought Roderick John Flower around $870,000.
Insider Trading History of Roderick John Flower
- 1
Roderick John Flower Trading Performance
Roderick John Flower Ownership Network
Roderick John Flower Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Roderick John Flower is the Director of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Roderick John Flower Mailing Address
Above is the net worth, insider trading, and ownership report for Roderick John Flower. Currently GuruFocus does not have mailing address information for Roderick John Flower.